-
Shading represents ≤5.0 % of patients achieving LDA (DAS28[ESR] ≤3.2) at week 28
- Numbers in brackets are the number of patients who achieved LDA at week 28, over the number of patients not achieving the SJC %, DAS28(ESR) or CDAI change threshold at any week up to the week presented
-
CZP certolizumab pegol, OL open-label, LDA low disease activity, DAS28 Disease Activity Score in 28 joints, CRP C-reactive protein, SJC swollen joint count, CDAI Clinical Disease Activity Index, TNF tumor necrosis factor, ESR erythrocyte sedimentation rate